Researchers around the world have been racing to develop a vaccine for the Zika virus, and it appears that a large team of US researchers have developed two very promising candidates.
According to a report published in the journal Nature, researchers developed one potential vaccine using a Zika virus isolated in Brazil, and another candidate using a Zika virus isolated in Puerto Rico. Preclinical results showed both candidates were able to protect mice against an infection with the Zika virus by stimulating the rodents’ immune system. Furthermore, neither candidate was found to have significant side effects. Read More